Nabriva Therapeutics Plc (NBRV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NBRV | AMGN | VRTX | REGN | BMY |
| Company | Nabriva Therapeutics Plc | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 1.4500 | 312.89 | 420.67 | 970.00 | 44.75 |
| High | 1.9000 | 314.89 | 422.57 | 979.98 | 44.88 |
| Low | 1.3500 | 309.82 | 417.50 | 966.85 | 44.30 |
| Last | 1.4200 | 311.39 | 422.55 | 975.40 | 44.81 |
| Change | unch | -1.47 | +3.56 | +7.40 | +0.07 |
| % Change | unch | -0.47% | +0.85% | +0.76% | +0.16% |
| Volume | 717,200 | 1,725,187 | 613,286 | 167,950 | 4,971,993 |
| 20-Day Average Volume | 46,640 | 2,884,254 | 1,084,124 | 482,062 | 13,971,329 |
| Previous Close | 1.4200 | 312.86 | 418.99 | 968.00 | 44.74 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.5446 | 281.64 | 401.93 | 919.12 | 46.00 |
| 20-Day Raw Stochastic | 12.73% | 80.85% | 91.11% | 96.36% | 23.16% |
| 20-Day Relative Strength | 42.54% | 66.39% | 62.19% | 61.83% | 35.92% |
| Weighted Alpha | -50.30 | +34.38 | +22.83 | +31.93 | -34.62 |
| Today's Opinion | 100% Sell | 56% Buy | 56% Buy | 72% Buy | 100% Sell |
| Previous Opinion | 100% Sell | 56% Buy | 56% Buy | 72% Buy | 100% Sell |
| Last Month's Opinion | 88% Sell | 40% Sell | 24% Buy | 40% Buy | 56% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -12.35% since 07/24/23 | -0.18% since 05/03/24 | +5.36% since 05/03/24 | +2.00% since 05/03/24 | +1.78% since 05/03/24 |
| Low | 1.3500 on 07/31/23 | 297.52 on 05/06/24 | 394.03 on 05/07/24 | 950.27 on 05/06/24 | 43.49 on 05/09/24 |
| High | 1.9000 on 07/31/23 | 314.89 on 05/10/24 | 425.65 on 05/08/24 | 979.98 on 05/10/24 | 44.88 on 05/10/24 |
| 1-Month | |||||
| %Chg | -5.96% since 06/30/23 | +16.62% since 04/10/24 | +6.29% since 04/10/24 | +4.27% since 04/10/24 | -10.97% since 04/10/24 |
| Low | 1.3500 on 07/31/23 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 1.9000 on 07/31/23 | 322.60 on 05/03/24 | 425.65 on 05/08/24 | 979.98 on 05/10/24 | 50.58 on 04/11/24 |
| 3-Month | |||||
| %Chg | -11.26% since 04/28/23 | +6.74% since 02/09/24 | -0.08% since 02/09/24 | +2.39% since 02/09/24 | -10.11% since 02/09/24 |
| Low | 1.3500 on 07/31/23 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 2.2400 on 05/19/23 | 322.60 on 05/03/24 | 437.00 on 02/27/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| 6-Month | |||||
| %Chg | -8.39% since 01/30/23 | +16.25% since 11/10/23 | +13.09% since 11/10/23 | +22.18% since 11/10/23 | -11.53% since 11/10/23 |
| Low | 1.2600 on 03/27/23 | 260.52 on 11/21/23 | 341.90 on 11/16/23 | 784.96 on 11/15/23 | 43.33 on 05/02/24 |
| High | 2.2400 on 05/19/23 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 45,461 | 167,829,040 | 108,121,632 | 106,249,616 | 90,692,464 |
| Shares Outstanding, K | 32,015 | 536,435 | 258,053 | 109,762 | 2,027,100 |
| Annual Sales | 36,940,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 45,006,000,000 |
| Annual Net Income | -57,190,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 8,025,000,000 |
| Last Quarter Sales | 7,590,000 | 7,447,000,000 | 2,517,700,000 | 3,145,000,000 | 11,865,000,000 |
| Last Quarter Net Income | -8,700,000 | -113,000,000 | 968,800,000 | 722,000,000 | -11,911,000,000 |
| 60-Month Beta | 1.53 | 0.60 | 0.39 | 0.17 | 0.45 |
| Per-Share Information | |||||
| Most Recent Earnings | -2.72 on 05/22/23 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | -4.40 on 04/25/24 |
| Latest Earnings Date | 08/02/23 | 05/02/24 | 05/06/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | N/A | N/A | 0.600 on 04/04/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 04/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.50 | 27.81 | 25.75 | 41.59 |